Posted by Michael Wonder on 18 Dec 2019
Funding of vitamin A oral liquid
18 December 2019 - PHARMAC is pleased to announce that PHARMAC has approved the use of the Exceptional Circumstances framework to provide funding of vitamin A oral liquid for a targeted group of patients.
The process used for the application and approval process is the same as that available for the funding of alpha tocopheryl acetate (Micelle E).
